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Abstract
Background: The World Health Organization recently recognized a family of neoplasms showing
at least partial morphological or immunohistochemical evidence of a putative perivascular epithelioid
cell (PEC) differentiation. These tumors include angiomyolipoma (AML), clear cell "sugar" tumors
of the lung (CCST), lymphangioleiomyomatosis (LAM), clear cell myomelanocytic tumors of the
falciform ligament and distinctive clear cell tumors at various other anatomic sites.
Case presentation & methods: A 41-year old gravida-1 para-1 with tuberous sclerosis
presented with an incidentally identified 2.2 cm mass. The morphology and immunohistochemical
profile was consistent with PEComa. Distinct aggregates of HMB-45 epithelioid cells were present
in an occasionally distinctive perivascular distribution in the myometrium, small bowel lamina
propria and ovarian hila. These distinctive aggregates, for which we propose the designation
"PEComatosis" based on their intraabdominal distribution, did not display cytological atypia, mitotic
activity or necrosis. CGH and DNA ploidy analysis showed a balanced chromosomal profile and
diploid nuclei, respectively. There was no recurrence or metastases at 35 months' follow-up. Fifty-
one previously reported cases of non-AML, LAM and CCST PEComas [perivascular epithelioid cell
tumors- not otherwise specified (PEComa-NOS)] are reviewed.
Conclusions: The lesions may be a reflection of tumor multicentricity, in which each may be a
potential nidus for the development of future more well-developed tumors. Alternatively, they may
be a manifestation of a poorly understood "field effect", in which there is an increased propensity
to develop tumors of this type throughout the abdomen. Finally, and least likely in our opinion, they
may represent tumor spread from its primary site.
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Background
Perivascular epithelioid cell tumors (PEComa) have been
the subject of abundant discussion in the medical literature
over the past decade [1-47]. Morphologic and immunophe-
notypic similarities between some constituent cells of renal
angiomyolipomas (AML) and those of a case of clear cell
"sugar" tumor of the lung (CCST) were initially noted in
1991 [33]. One year later, Bonetti et al [4], formally pro-
posed the concept of "perivascular epithelioid cell" (PEC), a
then provisional term meant to describe the epithelioid cells
that characterize, at least in part, the aforementioned
lesions. Characteristics of PEC (which does not have a nor-
mal anatomic homologue) include co-expression for
melanocytic and muscle markers, epithelioid to spindle cel-
lular shapes with ample clear to eosinophilic cytoplasm,
and at least in some cases, arrangement around blood ves-
sels [2]. Ultrastructurally, structures interpreted as melano-
somes and premelanosomes have been demonstrated in
some tumors composed of PECs [14,18,31,38], but not in
others [12,19,20,28,41]; an additional case showed macro-
scopic pigmentation [1]. In 1994, based on the morpho-
logic and immunophenotypic distinctiveness of PECs, in
addition to the fact that similar cells had been described in
some other tumors, Bonetti et al proposed the concept of a
family of lesions sharing this cellular phenotype, including
CCST, AML, and lymphangioleiomyomatosis (LAM) [5].
The term "PEComa" was introduced by Zamboni et al [42]
in 1996 as synonym for this family of tumors.
Over the past decade, PEC and tumors composed of them
have engendered significant discussions and controversies
with respect to their very existence as a clinico-pathological
entity, their histogenesis, pathogenesis, and nomenclature
[2-6,16,17,25,26,32,33,35,39,40]. Nonetheless, in 2002
and 2003, two monographs published under the auspices of
the World Health Organization (WHO) recognized a family
of neoplasms with perivascular epithelioid cell differentia-
tion and accepted the designation "PEComa" [13,21]. In the
WHO soft tissue volume, PEComas are defined as "mesen-
chymal tumors composed of histologically and immuno-
histochemically distinctive perivascular epithelioid cells"
[13]. Members of the PEComa family that were recognized
include AML, CCST, lymphangioleiomyomatosis (LAM),
clear cell myomelanocytic tumor (CCMMT) of the falciform
ligament/ ligamentum teres and a heterogeneous group of
other "unusual clear cell tumors" at various anatomic sites
[13]. The latter group includes tumors that have been
reported under varying designations, such as abdominopel-
vic sarcoma of perivascular epithelioid cells [6], primary
extrapulmonary sugar tumor (PEST) [38], clear cell myo-
melanocytic tumors of the skin [7] and thigh [15], and sim-
ply  PEComa  of various anatomic sites
[1,9,12,19,24,27,28,31,40,41,45,46]; these, in addition to
CCMMT of the falciform ligament [14] will henceforth be
referred to as PEComa not otherwise specified (PEComa
NOS). This descriptive designation, as used in this report,
excludes the well-established entities LAM, CCST of the
lungs and all variants of AML. Most of the reported cases of
PEComa NOS have been tumors located in the uterine cor-
pus (21/51; 41%); however, consequent to the publication
of the WHO monographs, there has been a recent noticea-
ble increase in the number of reported cases of PEComa
NOS, with almost 70% of all cases reported between 2001
and 2004 [1,6-8,10-
12,15,19,20,22,24,27,28,31,38,40,41,43-46](additional
file 1). Concurrently, there has been an increase in the diver-
sity of anatomic sites from which they reportedly arose, such
that, it now appears that these tumors may potentially arise
from any anatomic location. The morphologic and immu-
nophenotypic spectrum as well as exclusion/inclusion crite-
ria of PEComa NOS are not well-defined, and pathologic
parameters with prognostic value have yet to be elucidated.
In addition, there is a striking scarcity of information on the
molecular and cytogenetic data of these lesions, probably
due to their rarity. In this report, we present an example of a
PEComa NOS of the uterine cervix, with the following
objectives: 1) to document the uterine cervix as another
potential site for a PEComa NOS, 2) based on the presence
of tumorlets outside of their primary site, to analyze mor-
phologic criteria predictive of clinical behavior of PEComa
NOS, 3) to present CGH and ploidy analysis of PEComa
NOS, and 4) to present another example of a PEComa NOS
occurring in a tuberous sclerosis patient, an association
which has been documented only twice previously  [6,40]).
Case presentation
In October 2001, a left pelvic adnexal mass was palpated
during a routine physical examination of a 41-year-old grav-
ida-1 para-1 Caucasian female. The patient's past medical
history was significant for tuberous sclerosis (diagnosed pre-
viously based on seizures, radiographic evidence suggestive
of lymphangioleiomyomatosis, cutaneous hypopigmented
macules and bilateral cystic renal disease that culminated in
end-stage renal disease in 1989). A transvaginal ultrasound
showed a heterogeneous complex adnexal mass whose size
was estimated at 7.0 × 4.8 cm. Also noted was a well-defined
lesion (<1.0 cm) in the uterine cervix (figure 1); the clinical
impression of the latter lesion was a leiomyoma. CA-125
(13 U/ml) and CA19-9 (21 U/ml) levels were within nor-
mal limits. The decision was made to resect the adnexal
mass and in November 2001, the patient underwent a total
abdominal hysterectomy with bilateral salpingo-oophorec-
tomy. The surgical procedure was complicated by severe
intra abdominal adhesions (secondary to long-term perito-
neal dialysis), the lyses of which resulted in two inadvertent
nicks to small bowel segments that necessitated the  excision
of those segments. The patient did not receive any adjuvant
or neoadjuvant therapy, and she remains alive with no evi-
dence of recurrent or metastatic disease after 35 months of
close surveillance.World Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
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Sample preparation
Standard representative sections, including the entirety of
the uterine cervix were processed routinely for micro-
scopic examination. Sections were fixed in 10% neutral
buffered formalin, embedded in paraffin and stained with
hematoxylin and eosin. Selected sections were stained for
Periodic Acid Schiff (PAS) with and without diastase pre-
digestion. The immunohistochemical profile of the tumor
was evaluated on 4µ thick, formalin-fixed, deparaffinized
sections using a DAKO Autostainer (Carpinteria, CA,
USA) based on the avidin-biotin-peroxidase complex.
Specifications for the various immunohistochemical
stains that were utilized are listed in table 1. The extent
and intensity of the immunoreactivity for each antibody
was scored semi-quantitatively on a 1+(+) to 4+(++++)
scale representing increasing staining extent and intensity.
Labeling index for Ki-67 was calculated by assessing at
least 4000 cells and determining the percentage showing
unequivocal nuclear staining. In our literature review, the
significance of the differences between the group means
of two continuous variables (patient age and sizes of
lesions) was determined using the student's t-test (Excel®,
Microsoft Inc, Redmond, WA). DNA ploidy analysis was
performed on isolated tumor nuclei according to standard
procedures. Comparative genomic hybridization [48] was
performed on tumor tissue samples from the cervical
mass as previously described [49].
Pathological findings
Gross and microscopic assessment of the left adnexal
mass showed it to be a 7 cm hemorrhagic cyst devoid of
any specific lining and involving the ovarian parenchyma.
For the uterine cervical mass, a distinct lesion was not
grossly appreciated. The ectocervical and endocervical sur-
faces and the endometrial cavity were described as unre-
markable. Microscopically, the cervical mass was
unencapsulated but possessed a deceptively circum-
scribed appearance at scanning magnification, attributa-
ble to the architectural homogeneity of its "core" (Figure
2). However, the peripheral regions of the tumor showed
a significant degree of infiltration. The tumor's maximal
dimension was estimated at 2.2 cm, extending from just
below the ectocervical basement membrane (Figure 3)
and extending proximally to the lower uterine segment
and attaining 2 cm in depth (the peripheral limits of the
tumor were at least 1 cm from the parametrial margins).
The aforementioned central "core" (1 cm) was probably
responsible for its radiographic appearance and consisted
of fascicles of spindle cells with a smooth muscle appear-
ance (Figure 4a). The spindle cells displayed bland nuclei
with regularly distributed chromatin and only rarely con-
spicuous nucleoli. Towards the periphery, the spindle
cells displayed increasingly PAS+, diastase sensitive cyto-
plasm (Figure 4b), although occasional cells displayed
dense eosinophilia. At its most peripheral regions, the
tumor was composed predominantly of solid sheets of
large epithelioid cells with bland nuclear features, abun-
dant clear cytoplasm, and well-defined cytoplasmic mem-
branes. Although predominantly solid in the epithelioid
regions, a pseudo-alveolar pattern was also evident (Fig-
ure 4c). At the most proximal regions near the lower uter-
Ultrasonographic appearance of the cervical mass showing it  to be deceptively circumscribed Figure 1
Ultrasonographic appearance of the cervical mass showing it 
to be deceptively circumscribed
Photomicrograph of panoramic view of the cervical mass  showing a central circular "core" Figure 2
Photomicrograph of panoramic view of the cervical mass 
showing a central circular "core"World Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
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ine segment, the tumor appeared to be "invading" in
single cells in a hyalinized stroma. The nuclei of the epi-
thelioid cells showed a mild to moderate degree of
nuclear atypia, manifested mostly as nucleomegaly and
irregularity of nuclear membranes in the absence of
hyperchromasia. Rare cells displayed bizarrely enlarged
nuclei and multinucleation with a "smudged" chromatin
pattern consistent with degenerative atypia (Figure 5).
Also identified in these regions were CD68+ foamy histi-
ocytes mostly in single cells but occasionally in aggregates
especially around the endocervical glands. No tumor
necrosis was identified and mitotic figures were extremely
sparse (<1/50 HPF). Small arching sinusoidal vessels were
prominent throughout the tumor, but no large mal-
formed vascular profiles were present. Pigment-laden cells
and adipocytes were not present in the cervical mass.
Small bowel segments measuring 21 cm in total length
were also processed. Grossly, irregular areas of transmural
thickening were noted. Microscopically, aggregates of epi-
thelioid cells with more eosinophillic cytoplasm and vac-
uolated cytoplasm were noted in the lamina propria in
two out of twelve sections (Figure 6). In the both ovaries,
similar aggregates of cells were present in a distinctive
perivascular location in the hilar regions. These aggregates
were either subendothelial (predominantly), adventitially
attached to affected vessels, or present as free aggregates in
the perihilar fat (Figure 7). Each measured less than 1 mm
in maximum dimension. No intraluminal tumor cells
were seen. CGH and DNA ploidy analysis of the cervical
mass showed a balanced chromosomal profile (figure 8)
and diploid nuclei, respectively. Immunohistochemically,
both the epithelioid cells and spindle cells stained dif-
fusely with HMB-45 (Figure 9) and Melan-A in a cytoplas-
mic pattern at all sites (cervix, ovary, bowel). Scattered
spindle cells showed unequivocal immunoreactivity for
Table 1: Immunohistochemistry: antibody specifications and results
Antibody Clone Dilution Antigen retrieval 
method
Vendor Results*
Spindle cells Epithelioid cells
HMB-45 HMB-45 1:200 None DakoCytomation 
Carpinteria, CA, USA
+++ +++
Vimentin V9 1:5 None Ventana, Tucson AZ, USA +++ +
Desmin D33 1:250 Trypsin Ventana +++ +
Progesterone receptor (PR) PGR 636 1:2 Steam¶ DakoCytomation ++ ++
Melan-A A103 1:40 Steam DakoCytomation +++ +++
Estrogen receptor (ER) 1D5 1:2 Steam DakoCytomation - -
Caldesmon H-CD 1:100 Steam DakoCytomation + -
Smooth muscle actin (SMA) 1A4 Neat None Sigma, St Louis, MO, USA +++ ++
Keratin AE1/AE3 1:1200 Trypsin Chemicon Int, Temecula, CA - -
S100 Polyclonal 1:2 Pronase DakoCytomation + -
Ki-67 (LI)¶ MIB-1 1:300 Steam DakoCytomation +(<1%) +(<1%)
CD68 PG-M1 1:4 Steam DakoCytomation - -
CD117 Polyclonal 1:200 Steam DakoCytomation - -
EMA E29 1:1000 None DakoCytomation - -
p53 D07 1:3200 Steam DakoCytomation - -
¶ Heat-induced epitope retrieval, 20 minutes in 10 mM citrate buffer in steam chamber, 20 minutes cooling down period.
¶ LI: Labeling Index
*Semi-quantitative scoring of combined extent and intensity of staining (+ to ++++)
At the tumor's advancing edge, it merges almost impercepti- bly with the sub-ectocervical stroma Figure 3
At the tumor's advancing edge, it merges almost impercepti-
bly with the sub-ectocervical stromaWorld Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
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S100 while the epithelioid cells were negative. Both com-
ponents showed at least focal immunoreactivity for mus-
cle markers: smooth muscle actin and desmin with the
spindle cells predominating both in the quantity of cell
stained and the intensity of staining where positive. The
complete immunohistochemical profile of the tumor is
shown in table 1.
The cervical mass displayed a morphologic spectrum from  purely spindle, smooth-muscle-like areas (figure 4a) to transi- tional areas composed of spindle cells with more clear cyto- plasm (figure 4b) to overtly epithelioid areas with abundant,  clear cytoplasm, which occasionally displayed a pseudo-alveo- lar appearance (figure 4c) Figure 4
The cervical mass displayed a morphologic spectrum from 
purely spindle, smooth-muscle-like areas (figure 4a) to transi-
tional areas composed of spindle cells with more clear cyto-
plasm (figure 4b) to overtly epithelioid areas with abundant, 
clear cytoplasm, which occasionally displayed a pseudo-alveo-
lar appearance (figure 4c)
Occasional cells showed degenerative multinucleation with a  "smudged" chromatin nuclear pattern consistent with degen- erative atypia Figure 5
Occasional cells showed degenerative multinucleation with a 
"smudged" chromatin nuclear pattern consistent with degen-
erative atypia
Aggregates of spindle to polygonal cells with eosinophillic to  clear cytoplasm was present in the lamina propria of the  excised small bowel segments Figure 6
Aggregates of spindle to polygonal cells with eosinophillic to 
clear cytoplasm was present in the lamina propria of the 
excised small bowel segments. These aggregates were HMB-
45-positive.World Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
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Result of literature review
Of the 51 cases of PEComa NOS that have been docu-
mented in the literature [1,6-8,10-12,14,15,19,20,22-
25,27,28,31,32,34,37,38,40-46], 90% (46/51) developed
in females and 41% (21/51) were described in the uterine
corpus. Follow-up information was unavailable (n = 7) or
too recent at the time of the report (n = 4) in 22% of cases
[7,10,14,15,34,40,43,46]. One patient whose tumor was
primary in the left atrium died postoperatively of "cardiac
failure thought to be due to nontumorous coronary artery
thromoboemboli" [37]. Two cases were excluded from
the following analysis (44, 45) based on insufficient mor-
phologic information (44) or inconsistence with our ana-
lytic paradigm (45). Of the remaining 37 cases
(additional file 2), the associated tumors behaved in a
benign fashion in 25 cases (68%). These tumors were con-
fined to their respective primary sites and showed no
evidence of recurrence or metastases with follow-up peri-
ods that ranged from 6 weeks to 22 years, and will
hereafter be referred to as the "benign cases"
[1,6,8,14,20,23,25,27,32,37,38,40,42,44]. However in
twelve cases, the tumors recurred after apparently com-
plete surgical resections, were either metastatic at
presentation or metastasized after long periods. Four of
these cases were ultimately fatal [6,19,22,28], and all 12
will hereafter be referred to as the "non-benign cases"
[6,11,12,14,19,22,24,28,31,41].
Clinical parameters were not particularly discriminatory
between the two groups: the average patient age of the
In the ovarian hila, similar tumor aggregates were associated with vascular structures in a subendothelial (figure 7A), intra- medial (Figure 7B), or para-adventitial (Figure 7C) pattern, but were also present freely in the hilar fat (Figure 7D) Figure 7
In the ovarian hila, similar tumor aggregates were associated with vascular structures in a subendothelial (figure 7A), intra-
medial (Figure 7B), or para-adventitial (Figure figrure 7C ) pattern, but were also present freely in the hilar fat (Figure 7D).World Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
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benign cases (37 years) was not significantly different
from that of the non-benign cases (43 years) [p = 0.56]
and there was a diversity of clinical presentations related
primarily to the sites of origin. The non-benign cases
(mean diameter of 11 cases: 7.5 cm) tended to be larger
than the benign cases (mean diameter of 24 cases: 4.54
cm); the statistical significance of the difference (p =
0.022) is maintained even when the outlier effect of the 1
case with a 20 cm diameter tumor reported by Folpe et al
[14] in the non-benign group is removed. Morphologic
features in the benign and non-benign cases are compared
below.
Discussion
We have presented herein the first documented case of a
PEComa NOS of the uterine cervix. In addition to the pri-
mary tumor, aggregates of HMB-45+ clear cells were
present at several other intraabdominal sites, including
the small bowel lamina propria, ovarian hila and
myometrium. Based on this pattern of distribution of
tumor cells, we propose the designation "PEComatosis"
to describe such aggregates. The morphogenetic basis for
the intraabdominal lesions remains unclear. The similar-
ity in morphologic features and immunophenotype
between the cervical and extracervical lesions suggests that
either a) both lesions arise from the same site or progeni-
tor, or b) they both represent tissue responses of different
degrees to the same stimulus. Several possibilities were
considered, all of which are necessarily speculative. The
lesions may be a reflection of tumor multicentricity, in
which each may be a potential nidus for the development
of future more well-developed tumors. Alternatively, they
may be a manifestation of a poorly understood "field
effect", in which there is an increased propensity to
develop tumors of this type throughout the abdomen.
Comparative genomic hybridization showing a balanced chromosomal profile Figure 8
Comparative genomic hybridization showing a balanced chromosomal profileWorld Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
Page 8 of 12
(page number not for citation purposes)
Finally, and least likely in our opinion, they represented
the tumor spread   from its primary site.
The diffuse occurrence of apparently heterologous tissue
is a well-known phenomenon in the peritoneal cavity.
These include leiomyomatosis peritonealis disseminata
(LPD), gliomatosis peritonei and the recently described dif-
fuse cartilaginous metaplasia of the peritoneum [50,52]. In
LPD, for example, diffusely distributed peritoneal nodules
of benign smooth muscle may proliferate or regress based
on the hormonal milieu of pregnancy [52]. In this
instance, circulating hormone levels are thought to repre-
sent the main stimuli underlying the proliferation of the
peritoneal lesions. Even though a uterine smooth muscle
tumor is associated with most cases, they are not thought
to be the origin of LPD [52]. In contrast, gliomatosis peri-
tonei  is believed to represent an overgrowth of glial
implants from ovarian teratomas [52]. In either instance,
the presence of diffuse intraperitoneal lesions associated
with these benign lesions (an ovarian teratoma and a
uterine leiomyoma) is deemed insufficient to assign them
a malignancy status [52]. These examples are directly rele-
vant to our case, in which a malignant potential has to be
assigned to a pathologically benign tumor that is showing
similar appearing cells remote from its primary site. In the
current case, the distinctive tropism of tumor cells for
vascular structures without true intraluminal foci, argues
against a hematogenous spread of tumor and argues for a
de novo proliferation of PEC at those sites. However,
whether these are foci that would have undergone involu-
tion or continued proliferating into tumor masses
remains unclear. Do these lesions represent a
manifestation of a poorly understood "field effect", in
which there is an increased propensity to develop tumors
of this type throughout abdomen? The most obvious
underlying condition in this particular patient is tuberous
sclerosis. A potentially comparable condition may exist in
the lungs. In a few patients with and without tuberous
sclerosis, a distinctive diffuse pulmonary interstitial pro-
liferation has been described [53-56]. These proliferations
are composed of clear HMB-45+ cells and are inconstantly
associated with LAM [50-53]. Whether a similar mecha-
nism is operational here is not clear. Although we do not
believe the extracervical lesions represent metastases, it
should be noted that contrary to the conventional para-
digm, molecular evidence is accumulating regarding the
"metastasis of benign tumor cells" in patients with tuber-
ous sclerosis, although this is currently limited to the renal
angiomyolipoma to pulmonary lymphangioleiomyoma-
tosis model [57].
The issues raised by this case highlight the absence of well-
established morphologic criteria predicting aggressiveness
or malignancy in PEComas. Based on an analysis of 31 of
the 51 reported cases detailed in Additional file 1, the fol-
lowing information is stated in the WHO monograph
regarding the aforementioned criteria [13]: "it appears
that PEComas displaying any combination of infiltrative
growth, marked hypercellularity, nuclear enlargement
and hyperchromasia, high mitotic activity, atypical
mitotic figures, and coagulative necrosis should be
regarded as malignant". However, while the presence of
all the mentioned features would probably assign malig-
nancy to any tumor, it is unclear what significance there is
of the presence or absence of individual features or small
combinations thereof.
Since the relevance of any set of pathologic criteria is ulti-
mately dependent on their correlation to clinical behavior
based on published experience, we analyzed in greater
detail the clinicopathologic features of those 12 cases in
which aggressive behavior was already manifest and com-
pared them to those of the 25 cases with benign out-
comes. It is well recognized by the authors that this
separation is artificial, the definitional threshold for
'aggressiveness" is low, and that for example the
recurrence of a tumor is by no means necessarily indica-
tive of its malignancy. Nonetheless, this separation allows
comparative analysis of groups of cases whose clinical
behaviors have been shown to be different.
With regard to morphologic appearance, some features
appeared to distinguish the two groups. Nuclear atypia
(nucleomegaly, multinucleation, pleomorphism etc) was
more likely to be present in the non-benign group, with
this feature described in 8 of the 10 cases in which a com-
ment was rendered. However, some degree of nuclear
atypia was also described in 9 of the 25 cases in the benign
All components of the tumor were HMB-45-positive Figure 9
All components of the tumor were HMB-45-positiveWorld Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
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group; the atypia in all of the latter cases were described as
"minimal" or mild to moderate. Two cases that, in our
opinion, showed the highest degree of nuclear atypia (in
addition to high mitotic activity and necrosis) were unfor-
tunately reported without follow-up information [10,34].
Mitotic activity was uniformly low in the benign group,
with no mitotic figures identified in 13/25 (52%) cases
and rare (<1/20HPF) mitotic figures found in the
remainder with information. However, for the purposes
of answering the more clinically relevant question, i.e.
segregation of the non-benign group, mitotic activity was
not useful. Only 3 of the 10 non-benign cases (in which
mitotic activity information was given) showed signifi-
cant mitotic activity (≥ 6/10HPF). In the remaining 7
cases, mitotic figures were described as "rare" (n = 3),
"low" (n = 2) and <1/20hpF (n = 2).
Necrosis was a common feature of cases in the non-
benign group, being present in 7 of 11 cases (64%), with
an 8th case described as showing "gelatinous-appearing
material" macroscopically [11]. In contrast, of the benign
group, necrosis was present in only 4 of the 18 (22%)
cases in which such information was stated. Additionally,
the necrosis in one of those 4 cases was described as "inf-
arct-type" (non-coagulative) [40]. However, one of the
benign cases was described as showing "scattered foci of
coagulative necrosis and hemorrhage" [8]. As can be antic-
ipated, lymphovascular invasion (LVI) by tumor was
more characteristic of tumors in the non-benign group as
compared to their benign counterparts: LVI was present in
4 out of 8 (50%) cases in the non-benign group and in
only one case in the benign group. The latter is Case 3 of
the "abdominopelvic sarcomas" described by Bonetti et al
[6]; this tumor was a 2.5 cm well-circumscribed pelvic
nodule, the patient showed no evidence of tumor recur-
rence or metastases at 6 months follow-up. For the pur-
poses of this analysis, we placed this case in the benign
group, definitionally based on the benign follow-up.
We also analyzed the degree and types of tumor infiltra-
tion as another potential discriminator between the
benign and non-benign groups. In what remains the larg-
est series of PEComa NOS reported to date, Vang and
Kempson [40] divided 8 uterine PEComas into 2 groups
(A and B) based on, in part, the degree of tumor infiltra-
tion. Of the group A, 75% of tumors showed a tongue-like
myometrial infiltration reminiscent of low-grade
endometrial stromal sarcoma while this type of infiltra-
tion was only focal in 75% of their group B tumors; all
cases were limited to the uterus. Due to the absence of fol-
low-up in 75% of their group A cases, the prognostic sig-
nificance of this classification is unclear. Two of the four
"hyalinized uterine mesenchymal neoplasms with HMB-
45-positive epithelioid cells" reported by Michal and
Zamecnik [25] showed a similar "tongue-like" infiltration
and had a benign follow-up. All of the 7 cases of CCMMT
reported by Folpe et al [14] "appeared circumscribed but
displayed an infiltrative pattern microscopically at the
periphery", a pattern remarkably similar to our case. One
of their 6 cases with follow-up showed evidence of pul-
monary metastases at 3 months, while follow-up was
unremarkable in others. This patient reportedly died of
other causes. Analysis of the usefulness of infiltration was
hampered somewhat by the absence of a comment on this
subject in some of the non-benign cases; however, it is
unlikely to be a criterion of significant use in isolation.
Only in 3 of 10 malignant cases infiltration was promi-
nent. In 4 of the 7 remaining cases in the non-benign
group, infiltration was not specifically noted; the latter
includes a well-circumscribed and encapsulated 9 cm mass
involving the terminal ileum and cecum [6] which metas-
tasized to the liver and the patient died in 28 months. The
7th and 8th cases showed only local infiltration [11,14].
Another case reported by Ruco et al [34], which we
excluded from our analysis of the non-benign cases due to
an absence of outcome information, consisted of a
partially necrotic 5 cm mass showing high mitotic activity
(11 m/10hpF) and was described as "poorly circum-
scribed". One of the cases described by Fukunaga [8],
which we have placed in the benign group showed focal
infiltrative growth. For the rest of the benign group, signif-
icant infiltration was not described in any case.
Table 2: Summary of pathologic features in reported cases of PEComa NOS
Pathologic feature* Non-Benign cases (n = 12) Benign cases (n = 25)
Cytologic atypia 8/10 (80%) 9/25 (36%)
Necrosis 7/11 (64%) 4/18 (22%)
Lymphovascular invasion 4/8 (50%) 1/11 (9.1%)
Size (average diameters) 7.5 cm (n = 11) 4.54 cm (n = 24)
Significant mitotic activity (6 mitoses per 10 high power fields or greater 3/10 (30%) 0/24 (0%)
* For each histological feature, the denominator represents the number of cases in which the information assessed was available in the published 
reports. See text for caveats, exceptions and more detailed analysisWorld Journal of Surgical Oncology 2004, 2:35 http://www.wjso.com/content/2/1/35
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Overall, the experience with PEComas NOS is currently
too limited to make a definitive assessment of prognostic
features. In addition, the above analysis presumes a bio-
logic homogeneity to tumors arising from various ana-
tomic sites (table 2). Nonetheless, from our analysis of the
reported cases with clinical outcomes as end-points,
necrosis and large tumor size (both of which were more
characteristic of tumors in the non-benign group) appears
to have the greatest discriminatory value. However, it is
likely that when more cases are described, combinations
of features will provide the greatest prognostic informa-
tion. In the present case, as previously noted, there was no
necrosis, mitotic activity or significant pleomorphism, but
there were tumor aggregates in the ovaries (perivascular)
myometrium, and small bowel. The fact that close surveil-
lance of our patient for 29 months has revealed no evi-
dence of tumor recurrence or metastases is suggestive of
tumor benignancy, although even that statement is tem-
pered by the cases of metastases developing after long
periods, up to 7 years in one case ([11], Additional file 1).
An important differential consideration for PEComas aris-
ing in the uterus is epithelioid smooth muscle tumors.
Vang and Kempson [40] expressed the opinion that PECo-
mas and epithelioid smooth muscle tumors "exist on a
morphologic spectrum" and recommended that HMB-45
staining be performed on all epithelioid tumors of the
uterus. The contrary view was expressed by Silva et al [58]
who demonstrated immunoreactivity for HMB-45 in 4
(80%) out of 5 "unequivocal uterine leiomyosarcomas"
with epithelioid features. They concluded that HMB-45
immunoreactivity is insufficient to designate these tumors
as PEComas and separate them from epithelioid smooth
muscle tumors. Zamecnik and Michal [59] found immu-
noreactivity for HMB-45 in four distinctively hyalinized
epithelioid mesenchymal tumors of the uterus, but all
four cases were negative for the other three melanogenesis
markers tested (Melan-A, tyrosinase and micropthalmia
transcription factor). The authors concluded that their
cases were closer linked to epithelioid smooth muscle
tumors than PEComas. In the report by Ruco et al [34],
twelve uterine leiomyomas, two of which were epithe-
lioid, were negative for HMB-45. In contrast, at least focal
HMB-45 positivity was demonstrated in 43 of 79 (54%)
typical (non-epithelioid) smooth muscle tumors of the
uterus in 2 combined series [60,61]. These somewhat con-
tradictory findings illustrate that at this time, the relation-
ship between epithelioid smooth muscle tumors and
PEComas (outside of their shared co-expression of
muscular markers) is unclear. However, since both
tumors are rare, we agree with Vang and Kempson [40]
that HMB-45 immunostaining should be performed on
all epithelioid uterine tumors, not only to better delineate
the features of both epithelioid smooth muscle tumors
and PEComas, but due to the possibility of an association
between the latter and the tuberous sclerosis complex
(TSC).
Although the association between some members of the
PEComa family (AML and LAM) and the tuberous sclero-
sis complex is well-known, this case represents only the
third case of a PEComa NOS reported to occur in a patient
with stigmata of this complex. Both of the previous cases
were primary in the uterus [6,40]. Even this seemingly low
rate of association (6%; 3/50) is almost certainly higher
than that associated with most tumors, and may thus
warrant an investigation for features of TSC in patients in
whom these tumors are diagnosed.
The validity of segregating a tumor group based almost
entirely on the clear appearance of constituent cells and
immunoreactivity for melanogenesis markers may be
proven if recurrent molecular or cytogenetic abnormali-
ties are identified in this group. However, remarkably
sparse information exists on the cytogenetic or molecular
pathogenesis of PEComa NOS. Using conventional
cytogenetics, Folpe et al [14] identified loss of X chromo-
some and a t(3;10) in 1 of 5 metaphases examined from a
case of CCMMT. RT-PCR analysis of one perivascular epi-
thelioid cell tumor has failed to show the EWS/ATF-1
fusion transcript from the t(12;22) characteristic of clear
cell sarcoma of soft parts – another differential considera-
tion [41]. No other cytogenetic analyses of PEComa NOS
have been reported to our knowledge. p53 does not
appear to be involved in the pathogenesis of these tumors,
as neither p53 mutations as determined by single-
stranded conformational pleomorphism analysis, nor
protein overexpression as determined by immunohisto-
chemistry have been identified [33]. Our case represents
the first PEComa NOS that has been studied by CGH.
Although this needs to be confirmed with more cases, the
absence of chromosomal gain or loss detectable by this
method, in additional to a diploid DNA content of our
case, suggests that karyotypical changes may not be fea-
tures of PEComa NOS.
In summary, we have documented herein the first case of
a PEComa NOS of the uterine cervix occurring in a tuber-
ous sclerosis patient. With the description of additional
cases, more insight into their behavior and predictive
morphologic parameters may be achieved.
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